A comment to improve tumor-treating fields therapy

被引:0
|
作者
Fioranelli, Massimo [1 ]
Sepehri, Alireza [1 ]
机构
[1] Ist Terapie Sistem Integrate, Via Flaminia 499, I-00191 Rome, Italy
来源
AIMS BIOENGINEERING | 2023年 / 10卷 / 01期
关键词
tumor; TTFields; therapy; bubble; blood;
D O I
10.3934/bioeng.2023002
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Recent investigations have shown that special frequencies and intensities of electromagnetic waves could control the differentiations of some types of cells. Using this fact, tumor-treating fields (TTFields) therapy has been proposed as a technique which uses alternating electric fields of intermediate frequency (similar to 100-500 kHz) and low intensity (1-3 V/cm) to disrupt the cell divisions of tumors. However, this technique may have harmful effects on ionic liquids around normal cells. For example, electrodes could induce an extra electrical current within blood vessels. To observe these effects, we connected electrodes to a slide that includes water and some extra ions and put them under a 1000x microscope. We found that some ions, microbes and cells move toward negative electrons and some go away. These attractions of cells by electrodes could cause the destruction of the brain. We also found some electrical currents within the liquid emerge which absorb or repel water molecules and induce some bubbles. If these types of bubbles arise within the blood vessels, they can exert a force on the membranes of normal cells and destroy them. To avoid these problems, we suggest that electrodes should be replaced by some electromagnetic sender/receiver which emits some special frequencies. These frequencies could be absorbed only by blood vessels around the tumors because these vessels may be created only to provide the needed food for tumor cells and thus have a different potential and electrical current as compared to vessels around normal cells. Thus, these tumor vessels could act as the antenna for TTFields.
引用
收藏
页码:13 / 23
页数:11
相关论文
共 50 条
  • [21] Association between conflict of interest and published position on tumor-treating fields for the treatment of glioblastoma
    Hayes, Michael J.
    Prasad, Vinay
    JOURNAL OF CANCER POLICY, 2019, 21
  • [22] Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series
    Ansstas, George
    Tran, David D.
    CASE REPORTS IN NEUROLOGY, 2016, 8 (01): : 1 - 9
  • [23] Case Report of Complete Radiological Response of a Thalamic Glioblastoma After Treatment With Proton Therapy Followed by Temozolomide and Tumor-Treating Fields
    Stein, Marco
    Dohmen, Hildegard
    Woelk, Bernhard
    Eberle, Fabian
    Kolodziej, Malgorzata
    Acker, Till
    Uhl, Eberhard
    Jensen, Alexandra
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [24] Multi-Institutional Patterns of Use of Tumor-Treating Fields for Patients with Malignant Pleural Mesothelioma
    Kutuk, Tugce
    Walker, Joshua M.
    Ballo, Matthew T.
    Cameron, Robert B.
    Alvarez, Jean Bustamante
    Chawla, Sheema
    Luk, Eric
    Behl, Deepti
    Dal Pra, Alan
    Morganstein, Neil
    Refaat, Tamer
    Sheybani, Arshin
    Squillante, Christian
    Zhang, Jun
    Kotecha, Rupesh
    CURRENT ONCOLOGY, 2023, 30 (06) : 5195 - 5200
  • [25] 5-Fluorouracil as a Tumor-Treating Field-Sensitizer in Colon Cancer Therapy
    Lee, Yeon-Joo
    Cho, Jae-Min
    Sai, Sei
    Oh, Ju Yeon
    Park, Ji-Ae
    Oh, Se Jong
    Park, Misun
    Kwon, Junhye
    Shin, Ui Sup
    Baek, Jeong-Hwa
    Lim, Sun Ha
    Song, Jie-Young
    Hwang, Sang-Gu
    Kim, Eun Ho
    CANCERS, 2019, 11 (12)
  • [26] Influence of Tumor-Treating Fields in a Young Patient With Primary Spinal Glioblastoma Multiforme (GBM): A Case Report of a Rare Tumor
    Mikobi, Emmanuel K.
    Voorhees, Gerard
    Mahmood, Aftab
    Gandhi, Arpit
    Bailey, Michael
    Phillips, Jacqueline
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [27] Perspective on the EF-14 trial and its implications for the role of tumor-treating fields in the management of glioblastoma
    Mohan, Suyash
    Chawla, Sanjeev
    Skolnik, Aaron
    Poptani, Harish
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S272 - S275
  • [28] Case report: durable response of gliomatosis cerebri with concurrent tumor-treating fields (TTFields) and chemoradiotherapy treatment
    Desjarlais, Alex M.
    Miller, Ryan
    Ali, Ayesha S.
    Niazi, Muneeb Z.
    Cappelli, Louis
    Glass, Jon
    Farrell, Christopher J.
    Shi, Wenyin
    CHINESE CLINICAL ONCOLOGY, 2023, 12 (06)
  • [29] Tumor-treating fields in combination with sorafenib curtails the growth of colorectal carcinoma by inactivating AKT/STAT3 signaling
    Kim, Eun Ho
    Lee, Won Seok
    Oh, Hoon-Kyu
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (08) : 2553 - 2561
  • [30] Using Computational Phantoms to Improve Delivery of Tumor Treating Fields (TTFields) to Patients
    Bomzon, Ze'ev
    Hershkovich, Hadas Sara
    Urman, Noa
    Chaudhry, Aafia
    Garcia-Carracedo, Dario
    Korshoej, Anders R.
    Weinberg, Uri
    Wenger, Cornelia
    Miranda, Pedro
    Wasserman, Yoram
    Kirson, Eilon D.
    Yoram
    2016 38TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2016, : 6461 - 6464